Inflammatory Bowel Disease Treatment in Cancer Patients—A Comprehensive Review
Inflammatory bowel disease (IBD) is a chronic disease for which medical treatment with immunomodulating drugs is increasingly used earlier to prevent disability. Additionally, cancer occurrence in IBD patients is increased for several reasons, either IBD-related or therapy-associated. Doctors are th...
Main Authors: | Daniel Conceição, Margarida R. Saraiva, Isadora Rosa, Isabel Claro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/12/3130 |
Similar Items
-
Therapeutic Management of Adults with Inflammatory Bowel Disease and Malignancies: A Clinical Challenge
by: Francesca Ferretti, et al.
Published: (2023-01-01) -
Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets
by: Patricia Teixeira Santana, et al.
Published: (2022-03-01) -
Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease
by: Wael El-Matary, et al.
Published: (2020-07-01) -
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention
by: Marianna Lucafò, et al.
Published: (2021-10-01) -
Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review
by: Alessandro Massano, et al.
Published: (2023-07-01)